Bioxcel Therapeutics's total assets for Q3 2024 were $48.89M, a decrease of -25.28% from the previous quarter. BTAI total liabilities were $134.53M for the fiscal quarter, a -3.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.